Pharmaceutical
Sosaria
Adrenergic Respiratory
Active ingredient
Salbutamol + ipratropium bromide
Pharmaceutical form
Salbutamol + ipratropium bromide
Pharmaceutical form
Solution for nebulisation or oral use
Dosage15 ml – 1 vial
IndicationsTreatment of bronchial asthma and obstructive pulmonary disease with asthma overlap; whenever it is necessary to associate an anticholinergic drug to a beta-adrenergic drug.